REQUEST A DEMO
Total
USD $0.00
Search more companies

Miralek-Farma OOO (Миралек-Фарма ООО) (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Miralek-Farma OOO Profile Updated: October 17, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Miralek-Farma OOO (Миралек-Фарма ООО) is an enterprise located in Russia, with the main office in Moscow. It operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on April 29, 2014. Miralek-Farma OOO (Миралек-Фарма ООО) currently employs 1 (2022) people. In its most recent financial highlights, the company reported a net sales revenue increase of 71.46% in 2024. Its’ total assets recorded a growth of 125.36%. The enterprise’s net profit margin increased by 13.43% in 2024.

Headquarters
Stromynka, 4, 1, 7
Moscow; Moscow; Postal Code: 107014

Contact Details: Purchase the Miralek-Farma OOO (Миралек-Фарма ООО) report to view the information.

Basic Information
Total Employees:
Purchase the Miralek-Farma OOO (Миралек-Фарма ООО) report to view the information.
Registered Capital:
Purchase the Miralek-Farma OOO (Миралек-Фарма ООО) report to view the information.
Financial Auditors:
Purchase the Miralek-Farma OOO (Миралек-Фарма ООО) report to view the information.
Incorporation Date:
April 29, 2014
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Miralek-Farma OOO (Миралек-Фарма ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
71.46%
Total operating revenue
71.46%
Operating profit (EBIT)
293.25%
Net Profit (Loss) for the Period
365.52%
Total Assets
125.36%
Total Equity
248.09%
Operating Profit Margin (ROS)
11.97%
Net Profit Margin
13.43%
Return on Equity (ROE)
17.98%
Debt/Equity
-53.13%
Quick Ratio
0.2%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?